Investor · CAMBRIDGE, MA

Steven Perrin

Open Steven in the network graph →

Filings

6

SEC Form D

Connections

25

co-filers

Capital

$92.9M

across filings

Active

Jun 2017

to May 2024

Most-connected co-filers (25)

Walter Ogier · Cambridge, MA5 shared David-Alexandre Gros · Rancho Santa Fe, CA3 shared Augie Nieto · CAMBRIDGE, MA3 shared Keith Katkin · Irvine, CA3 shared John Mcbride · Irvine, CA3 shared Maeve Mcnally · CAMBRIDGE, MA3 shared Bryan Smith · Kokomo, IN2 shared Gary Lyons · Irvine, CA2 shared June Lee · Irvine, CA2 shared Paul Little · Irvine, CA2 shared Jan Hillson · Irvine, CA2 shared Frederick Brumder · Portland, OR1 shared Paul Sallaberry · San Jose, CA1 shared Allan Kirk · RALEIGH, NC1 shared Kathleen L. Herrin · Chicago, IL1 shared Paolo Crozzoli · Luxembourg, Luxembourg1 shared Eric Craven · CAMBRIDGE, MA1 shared Jon Kuwahara · Irvine, CA1 shared Theodore Reich · CAMBRIDGE, MA1 shared John T. Lykouretzos · New York, NY1 shared Kent Bransford · CAMBRIDGE, MA1 shared James Robinson · San Francisco, CA1 shared Alphonse L. Iudicello · Chicago, IL1 shared [No Name] Boyd Watterson GSA GP, LLC · Cleveland, OH1 shared

Recent filings (6)

Eledon Pharmaceuticals, Inc.May 2024 · 22 co-filers Eledon Pharmaceuticals, Inc.May 2024 · 22 co-filers Eledon Pharmaceuticals, Inc.May 2023 · 22 co-filers Eledon Pharmaceuticals, Inc.May 2023 · 22 co-filers Novus Therapeutics, Inc.Sep 2020 · 13 co-filers$108.1M Novus Therapeutics, Inc.Sep 2020 · 13 co-filers$108.1M Anelixis Therapeutics, Inc.May 2019 · 7 co-filers$6.0M Anelixis Therapeutics, Inc.May 2019 · 7 co-filers$6.0M Anelixis Therapeutics, Inc.Apr 2018 · 7 co-filers$4.5M Anelixis Therapeutics, Inc.Apr 2018 · 7 co-filers$4.5M Anelixis Therapeutics, Inc.Jun 2017 · 15 co-filers$8.0M Anelixis Therapeutics, Inc.Jun 2017 · 15 co-filers$8.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Steven in the interactive graph →